Tenet Healthcare (THC) Projected to Release Quarterly Earnings on Thursday

Tenet Healthcare (NYSE:THC) is anticipated to post its Q3 2026 results before the market opens on Thursday, October 29th. Analysts expect the company to post earnings of $4.68 per share and revenue of $5.49 billion for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, October 29, 2026 at 10:00 AM ET.

Tenet Healthcare Price Performance

NYSE THC opened at $262.80 on Wednesday. The firm has a market capitalization of $21.16 billion, a price-to-earnings ratio of 10.13 and a beta of 1.20. The company’s fifty day moving average is $264.90 and its two-hundred day moving average is $219.31. Tenet Healthcare has a 52-week low of $157.58 and a 52-week high of $283.05.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Raymond James Financial reiterated an “outperform” rating and issued a $285.00 target price on shares of Tenet Healthcare in a research note on Friday, August 14th. The Goldman Sachs Group restated a “buy” rating and set a $305.00 price target on shares of Tenet Healthcare in a research note on Tuesday, July 28th. TD Cowen upped their price target on Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a report on Monday, July 27th. Guggenheim raised their price objective on Tenet Healthcare from $283.00 to $307.00 and gave the stock a “buy” rating in a research report on Friday, October 16th. Finally, Barclays raised their price objective on Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a research report on Friday, July 24th. Eighteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $278.45.

Insider Activity at Tenet Healthcare

In related news, Director J. Robert Kerrey sold 12,010 shares of the company’s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $263.72, for a total value of $3,167,277.20. Following the sale, the director owned 4,794 shares of the company’s stock, valued at $1,264,273.68. The trade was a 71.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Saumya Sutaria sold 50,000 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $278.71, for a total transaction of $13,935,500.00. Following the completion of the transaction, the chief executive officer directly owned 483,564 shares of the company’s stock, valued at $134,774,122.44. This trade represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 106,484 shares of company stock worth $28,898,063 in the last ninety days. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.